Recent studies demonstrated that tumors overexpressing the epidermal growth factor receptor (EGF-R, erbB-1) are associated with poor clinical outcome. This led to the development of a variety of monoclonal antibodies targeting the extracellular domain of this receptor tyrosine kinase. The aim of our
Inhibitory effect of anti-epidermal growth factor receptor antibody on a human gastric cancer
โ Scribed by Tadashi Teramoto; Masahiko Onda; Akira Tokunaga; Goro Asano
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- English
- Weight
- 625 KB
- Volume
- 77
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
โฆ Synopsis
The authors thank Dr. Takeshi Okuda for helpful discussion, Ms. Yumiko Tamagawa for animal care, and Mr. Hidemasa Takafuji for technical assistance.
๐ SIMILAR VOLUMES
The proliferation of human non-small-cell-lung-cancer (NSCLC) cells is regulated by the epidermal-growth-factorreceptor (EGFR)-mediated autocrine loop that interacts with transforming growth factor-โฃ (TGF-โฃ) of autocrine or paracrine origin. We have shown that EGFR expression is elevated in the brai
## Abstract The proteasome plays a pivotal role in the turnover of regulatory transduction proteins induced by activated cell membrane growth factor receptors. The epidermal growth factor receptor (EGFR) pathway is crucial in the development and progression of human epithelial cancers. Proteasome i